Details for 2010817793

Up to date per 02.04.2026

Actions

Title / Product Name

SYNERGISTISCHE ANTI-CD47-THERAPIE FÜR BLUTKREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2010817793

EP Publication Number

2477648

E-Number

1505114

Language

PCT Number

US10048992

Publication Date

25.07.2012 A

20.07.2022 B1

Registration Date

20.07.2022

AT Publication Date

15.08.2022

Application Date

15.09.2010

Registration Number

Priorities

15.09.2009

276726 P

IPC

A61K 39/00 20060101AFI20220209BHEP

Maximum Duration of Protection

15.09.2030

Owner

The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

WEISSMAN, Irving L.747 Santa Ynez Street Stanford, CA 94305US

MAJETI, RavindraStanford Institute for Stem Cell BIo and Regenerative Medicine 1050 Arastradero Road Building A Stanford, CA 94304US

ALIZADEH, Arash Ash328 Greenfield Avenue San Mateo, CA 94403US

CHAO, Mark P.2001 Showers Drive Mountain View, CA 94040US

Information about Fees